Release of HER2 repression of trefoil factor 3 (TFF3) expression mediates trastuzumab resistance in HER2+/ER+ mammary carcinoma

10.18632/oncotarget.18431

Saved in:

Bibliographic Details
Main Authors:	Chong, Q.-Y, You, M.-L, Pandey, V, Banerjee, A, Chen, Y.-J, Poh, H.-M, Zhang, M, Ma, L, Zhu, T, Basappa, Laboratory of Chemical Biology, Department of Chemistry, Bangalore University, Central College Campus, Bangalore, India, Liu, L, Lobie, P.E
Other Authors:	CANCER SCIENCE INSTITUTE OF SINGAPORE
Format:	Article
Published:	Impact Journals LLC 2020
Subjects:	epidermal growth factor receptor epidermal growth factor receptor 2 estrogen receptor estrogen receptor alpha her 1 protein her 3 protein her 4 protein small interfering RNA trastuzumab trefoil factor 3 tumor marker unclassified drug Article breast cancer cell line breast carcinoma cancer growth cancer resistance cancer stem cell cancer survival cell function controlled study disease association disease marker drug sensitization drug targeting estrogen receptor positive breast cancer human human cell immunoblotting polymerase chain reaction protein expression protein family protein function regulatory mechanism signal transduction transcription regulation upregulation Western blotting
Online Access:	https://scholarbank.nus.edu.sg/handle/10635/174441
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore

id	sg-nus-scholar.10635-174441
record_format	dspace
spelling	sg-nus-scholar.10635-1744412023-09-21T08:54:18Z Release of HER2 repression of trefoil factor 3 (TFF3) expression mediates trastuzumab resistance in HER2+/ER+ mammary carcinoma Chong, Q.-Y You, M.-L Pandey, V Banerjee, A Chen, Y.-J Poh, H.-M Zhang, M Ma, L Zhu, T Basappa, Laboratory of Chemical Biology, Department of Chemistry, Bangalore University, Central College Campus, Bangalore, India Liu, L Lobie, P.E CANCER SCIENCE INSTITUTE OF SINGAPORE DEPT OF PHARMACOLOGY epidermal growth factor receptor epidermal growth factor receptor 2 estrogen receptor estrogen receptor alpha her 1 protein her 3 protein her 4 protein small interfering RNA trastuzumab trefoil factor 3 tumor marker unclassified drug Article breast cancer cell line breast carcinoma cancer growth cancer resistance cancer stem cell cancer survival cell function controlled study disease association disease marker drug sensitization drug targeting estrogen receptor positive breast cancer human human cell immunoblotting polymerase chain reaction protein expression protein family protein function regulatory mechanism signal transduction transcription regulation upregulation Western blotting 10.18632/oncotarget.18431 Oncotarget 8 43 74188-74208 2020-09-04T03:44:43Z 2020-09-04T03:44:43Z 2017 Article Chong, Q.-Y, You, M.-L, Pandey, V, Banerjee, A, Chen, Y.-J, Poh, H.-M, Zhang, M, Ma, L, Zhu, T, Basappa, Laboratory of Chemical Biology, Department of Chemistry, Bangalore University, Central College Campus, Bangalore, India, Liu, L, Lobie, P.E (2017). Release of HER2 repression of trefoil factor 3 (TFF3) expression mediates trastuzumab resistance in HER2+/ER+ mammary carcinoma. Oncotarget 8 (43) : 74188-74208. ScholarBank@NUS Repository. https://doi.org/10.18632/oncotarget.18431 1949-2553 https://scholarbank.nus.edu.sg/handle/10635/174441 Impact Journals LLC Unpaywall 20200831
institution	National University of Singapore
building	NUS Library
continent	Asia
country	Singapore Singapore
content_provider	NUS Library
collection	ScholarBank@NUS
topic	epidermal growth factor receptor epidermal growth factor receptor 2 estrogen receptor estrogen receptor alpha her 1 protein her 3 protein her 4 protein small interfering RNA trastuzumab trefoil factor 3 tumor marker unclassified drug Article breast cancer cell line breast carcinoma cancer growth cancer resistance cancer stem cell cancer survival cell function controlled study disease association disease marker drug sensitization drug targeting estrogen receptor positive breast cancer human human cell immunoblotting polymerase chain reaction protein expression protein family protein function regulatory mechanism signal transduction transcription regulation upregulation Western blotting
spellingShingle	epidermal growth factor receptor epidermal growth factor receptor 2 estrogen receptor estrogen receptor alpha her 1 protein her 3 protein her 4 protein small interfering RNA trastuzumab trefoil factor 3 tumor marker unclassified drug Article breast cancer cell line breast carcinoma cancer growth cancer resistance cancer stem cell cancer survival cell function controlled study disease association disease marker drug sensitization drug targeting estrogen receptor positive breast cancer human human cell immunoblotting polymerase chain reaction protein expression protein family protein function regulatory mechanism signal transduction transcription regulation upregulation Western blotting Chong, Q.-Y You, M.-L Pandey, V Banerjee, A Chen, Y.-J Poh, H.-M Zhang, M Ma, L Zhu, T Basappa, Laboratory of Chemical Biology, Department of Chemistry, Bangalore University, Central College Campus, Bangalore, India Liu, L Lobie, P.E Release of HER2 repression of trefoil factor 3 (TFF3) expression mediates trastuzumab resistance in HER2+/ER+ mammary carcinoma
description	10.18632/oncotarget.18431
author2	CANCER SCIENCE INSTITUTE OF SINGAPORE
author_facet	CANCER SCIENCE INSTITUTE OF SINGAPORE Chong, Q.-Y You, M.-L Pandey, V Banerjee, A Chen, Y.-J Poh, H.-M Zhang, M Ma, L Zhu, T Basappa, Laboratory of Chemical Biology, Department of Chemistry, Bangalore University, Central College Campus, Bangalore, India Liu, L Lobie, P.E
format	Article
author	Chong, Q.-Y You, M.-L Pandey, V Banerjee, A Chen, Y.-J Poh, H.-M Zhang, M Ma, L Zhu, T Basappa, Laboratory of Chemical Biology, Department of Chemistry, Bangalore University, Central College Campus, Bangalore, India Liu, L Lobie, P.E
author_sort	Chong, Q.-Y
title	Release of HER2 repression of trefoil factor 3 (TFF3) expression mediates trastuzumab resistance in HER2+/ER+ mammary carcinoma
title_short	Release of HER2 repression of trefoil factor 3 (TFF3) expression mediates trastuzumab resistance in HER2+/ER+ mammary carcinoma
title_full	Release of HER2 repression of trefoil factor 3 (TFF3) expression mediates trastuzumab resistance in HER2+/ER+ mammary carcinoma
title_fullStr	Release of HER2 repression of trefoil factor 3 (TFF3) expression mediates trastuzumab resistance in HER2+/ER+ mammary carcinoma
title_full_unstemmed	Release of HER2 repression of trefoil factor 3 (TFF3) expression mediates trastuzumab resistance in HER2+/ER+ mammary carcinoma
title_sort	release of her2 repression of trefoil factor 3 (tff3) expression mediates trastuzumab resistance in her2+/er+ mammary carcinoma
publisher	Impact Journals LLC
publishDate	2020
url	https://scholarbank.nus.edu.sg/handle/10635/174441
_version_	1778169762154545152

Release of HER2 repression of trefoil factor 3 (TFF3) expression mediates trastuzumab resistance in HER2+/ER+ mammary carcinoma

Similar Items